Why the study?
NAFLD is increasing due to sedentary lifestyle and obesity, prompting evaluation of CRP levels, their association with simple steatosis versus NASH, and their diagnostic value.
Does C-reactive protein (CRP) level differentiate between simple steatosis and non-alcoholic steatohepatitis (NASH) in patients with non-alcoholic fatty liver disease?
Does C-reactive protein (CRP) level differentiate between simple steatosis and non-alcoholic steatohepatitis (NASH) in patients with non-alcoholic fatty liver disease?
CRP levels are significantly elevated in patients with NASH compared to those with simple steatosis and healthy controls, suggesting it may serve as a useful non-invasive biomarker for differentiation.
CRP may differentiate NASH from steatosis; leaves open diagnostic utility pending validation.
Aim: Non-alcoholic fatty liver disease (NAFLD) is a broad-spectrum disease that has increased in recent years due to increased sedentary life and obesity. It was aimed to determine C-reactive protein (CRP) levels, its association with simple steatosis and non-alcoholic steatohepatitis (NASH) and its diagnostic value in this study. Methods: A total of 165 patients had a diagnosis of fatty liver disease (simple steatosis group and NASH group) and 99 healthy controls without liver disease were included in the study. Aspartate aminotransferase (AST), alanine aminotransferase (ALT), total bilirubin, direct bilirubin, CRP levels were evaluated and ultrasonographic evaluation of liver was performed in all groups. Histopathological evaluation was performed by biopsy in 65 patients who were thought to have NASH. Results: AST and ALT values were found to be significantly higher in the NASH group than the other groups. CRP levels were detected lowest in control group and highest in NASH group (p <0.001). AST values were also found to be significantly higher in patients with fibrosis grade 3-4 compared to the control group. Conclusion: Our study showed that CRP level is a suitable marker for differentiation of simple steatosis and NASH.
No takes yet. Share an insight, caveat, or question.
GÜNAY et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: